Cognitive Impairment Associated with Schizophrenia: a Review of the Humanistic Burden

被引:55
|
作者
Kitchen, Helen [1 ]
Rofail, Diana
Heron, Louise
Sacco, Pat [2 ]
机构
[1] Adelphi Mill, Adelphi Values, Bollington SK10 5JB, Cheshire, England
[2] Novartis Pharmaceut, E Hanover, NJ USA
关键词
burden; cognitive impairment associated with schizophrenia; conceptual model; cost; humanistic; patient reported outcome; schizophrenia; QUALITY-OF-LIFE; ANTIPSYCHOTIC MEDICATIONS; 2ND-GENERATION ANTIPSYCHOTICS; CONVENTIONAL ANTIPSYCHOTICS; 1ST-EPISODE SCHIZOPHRENIA; ATYPICAL ANTIPSYCHOTICS; EXECUTIVE FUNCTION; NEGATIVE SYMPTOMS; ECONOMIC BURDEN; UNITED-STATES;
D O I
10.1007/s12325-012-0001-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction: Nearly every individual with schizophrenia is affected by cognitive decline. The aim of this literature review was to: (a) describe the humanistic burden of cognitive impairment associated with schizophrenia (CIAS); (b) develop a conceptual model that depicts the signs and symptoms of CIAS along with key concepts important to patients; and (c) consider the adequacy of potential patient-reported outcome (PRO) instruments for assessing future treatments. Methods: The following electronic databases were searched for articles published between January 1999 and November 2009 related to CIAS and PROs, or cost of illness: Medline; Embase; PsycINFO; the Health Economic Evaluation Database; and the National Health Service Economic Evaluation Database and Health Technology Assessment databases at the Centre for Reviews and Dissemination, University of York. Results: The literature search revealed 3950 abstracts, of which 101 articles were reviewed in detail. Cognitive functions affected include memory, attention/concentration, problem solving, learning, executive function, processing speed, and social cognition. Cognitive impairment impacts the ability of individuals to carry out activities of daily living, work productively, function socially, and adhere to treatment. These effects have economic ramifications through increased direct and indirect costs associated with the treatment of schizophrenia. The literature revealed 39 PRO instruments that have been used to assess functioning. However, no single instrument captures all key concepts of importance to patients with schizophrenia. Conclusion: The significant burden from CIAS for patients and society has implications for designing future treatments and health strategies to improve functional outcomes.
引用
收藏
页码:148 / 162
页数:15
相关论文
共 50 条
  • [21] Reducing Burden for Caregivers of Older Adults With Mild Cognitive Impairment: A Systematic Review
    Domingues, Nelia Sofia
    Verreault, Phylicia
    Hudon, Carol
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2018, 33 (07): : 401 - 414
  • [22] The entorhinal cortex and cognitive impairment in schizophrenia: A comprehensive review
    Li, Kun
    Qian, Liju
    Zhang, Chenchen
    Zhang, Jiajia
    Xue, Chuang
    Zhang, Yuebing
    Deng, Wei
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2025, 136
  • [23] Neurodevelopmental origin of cognitive impairment in schizophrenia
    Bora, E.
    PSYCHOLOGICAL MEDICINE, 2015, 45 (01) : 1 - 9
  • [24] Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis
    Tanzer, Timothy
    Shah, Shelukumar
    Benson, Catherine
    De Monte, Veronica
    Gore-Jones, Victoria
    Rossell, Susan L.
    Dark, Frances
    Kisely, Steve
    Siskind, Dan
    Melo, Catarina Drumonde
    PSYCHOPHARMACOLOGY, 2020, 237 (01) : 11 - 19
  • [25] Efficacy and safety of non-invasive brain stimulation on cognitive function for cognitive impairment associated with schizophrenia: A systematic review and meta-analysis
    Li, Xueyan
    Dai, Jie
    Liu, Qingran
    Zhao, Zhenying
    Zhang, Xiaofeng
    JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 170 : 174 - 186
  • [26] Apathy Is Associated With Increased Amyloid Burden in Mild Cognitive Impairment
    Marshall, Gad A.
    Donovan, Nancy J.
    Lorius, Natacha
    Gidicsin, Christopher M.
    Maye, Jacqueline
    Pepin, Lesley C.
    Becker, J. Alex
    Amariglio, Rebecca E.
    Rentz, Dorene M.
    Sperling, Reisa A.
    Johnson, Keith A.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 25 (04) : 302 - 307
  • [27] New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment
    Faris, Pawan
    Pischedda, Doris
    Palesi, Fulvia
    D'Angelo, Egidio
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2024, 18
  • [28] Glymphatic System Dysfunction Underlying Schizophrenia Is Associated With Cognitive Impairment
    Tu, Ye
    Fang, Yan
    Li, Guohui
    Xiong, Fei
    Gao, Feng
    SCHIZOPHRENIA BULLETIN, 2024, 50 (05) : 1223 - 1231
  • [29] Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia
    Xiang Yang Zhang
    Jun Liang
    Da Chun Chen
    Mei Hong Xiu
    Fu De Yang
    Therese A. Kosten
    Thomas R. Kosten
    Psychopharmacology, 2012, 222 : 277 - 284
  • [30] Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia
    Zhang, Xiang Yang
    Liang, Jun
    Chen, Da Chun
    Xiu, Mei Hong
    Yang, Fu De
    Kosten, Therese A.
    Kosten, Thomas R.
    PSYCHOPHARMACOLOGY, 2012, 222 (02) : 277 - 284